Drugs that contain Bupivacaine; Meloxicam

1. Drug name - ZYNRELEF KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9592227 HERON THERAPS INC Compositions of a polyorthoester and an aprotic solvent Mar, 2034

(11 years from now)

US9913909 HERON THERAPS INC Compositions of a polyorthoester and an aprotic solvent Mar, 2034

(11 years from now)

US11253504 HERON THERAPS INC Compositions of a polyorthoester and an aprotic solvent Mar, 2034

(11 years from now)

US10398686 HERON THERAPS INC Compositions of a polyorthoester and an aprotic solvent Mar, 2034

(11 years from now)

US9744163 HERON THERAPS INC Compositions of a polyorthoester and an aprotic solvent Mar, 2034

(11 years from now)

US10098957 HERON THERAPS INC Long-acting polymeric delivery systems Apr, 2035

(12 years from now)

US10632199 HERON THERAPS INC Long-acting polymeric delivery systems Apr, 2035

(12 years from now)

US10898575 HERON THERAPS INC Long-acting polymeric delivery systems Apr, 2035

(12 years from now)

US11083797 HERON THERAPS INC Long-acting polymeric delivery systems Apr, 2035

(12 years from now)

US10980886 HERON THERAPS INC Compositions of a polyorthoester and an organic acid excipient Apr, 2035

(12 years from now)

US9694079 HERON THERAPS INC Long-acting polymeric delivery systems Apr, 2035

(12 years from now)

US9801945 HERON THERAPS INC Long-acting polymeric delivery systems Apr, 2035

(12 years from now)

US10213510 HERON THERAPS INC Long-acting polymeric delivery systems Apr, 2035

(12 years from now)

US11083730 HERON THERAPS INC Long-acting polymeric delivery systems Apr, 2035

(12 years from now)

Treatment: Treatment of postsurgical pain providing analgesia to a patient for up to 72 hours, for example, after bunionectomy, open inguinal herniorrhaphy, or total knee arthroplasty via soft tissue or periarticular instillation

Dosage: SOLUTION, EXTENDED RELEASE;PERIARTICULAR

More Information on Dosage
Strength Dosage Availability
60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) SOLUTION, EXTENDED RELEASE;PERIARTICULAR Prescription
200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) SOLUTION, EXTENDED RELEASE;PERIARTICULAR Prescription
300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) SOLUTION, EXTENDED RELEASE;PERIARTICULAR Prescription
400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) SOLUTION, EXTENDED RELEASE;PERIARTICULAR Prescription

availability in other generic markets.

Click on the highlighted region to filter.